United States · FDA National Drug Code directory
Bupropion Hydrochloride XL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-3331_89d479c9-2544-4328-bb0b-234cdbe3ca52
- Product NDC
- 0591-3331
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Bupropion Hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20081126
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-05) · 0591-3331-05
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-19) · 0591-3331-19
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-30) · 0591-3331-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →